Meeder Advisory Services’s AbbVie ABBV Stock Holding History

Meeder Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Sell	51,588 -202	-0.4%	-$43.5K	0.48%	38
2026 Q1	$11.3M	Buy	51,790 +1,860	+4%	+$413K	0.47%	32
2025 Q4	$11.4M	Buy	49,930 +1,792	+4%	+$408K	0.49%	35
2025 Q3	$11.1M	Buy	48,138 +3,268	+7%	+$665K	0.52%	34
2025 Q2	$8.33M	Buy	44,870 +1,511	+3%	+$281K	0.43%	38
2025 Q1	$9.08M	Buy	43,359 +4,375	+11%	+$851K	0.54%	34
2024 Q4	$6.93M	Sell	38,984 -138	-0.4%	-$25.4K	0.43%	38
2024 Q3	$7.73M	Buy	39,122 +1,173	+3%	+$219K	0.5%	33
2024 Q2	$6.51M	Buy	37,949 +8,353	+28%	+$1.38M	0.46%	35
2024 Q1	$5.39M	Buy	29,596 +1,006	+4%	+$173K	0.55%	29
2023 Q4	$4.43M	Buy	28,590 +546	+2%	+$79.6K	0.51%	32
2023 Q3	$4.18M	Sell	28,044 -3,978	-12%	-$584K	0.53%	34
2023 Q2	$4.31M	Sell	32,022 -3,064	-9%	-$449K	0.46%	38
2023 Q1	$5.59M	Buy	35,086 +2,441	+7%	+$373K	0.64%	26
2022 Q4	$5.28M	Buy	+32,645	New	+$5.01M	0.67%	26

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Meeder Advisory Services's ABBV Position: Q2 2026 in Review

Meeder Advisory Services reduced its AbbVie (ABBV) stake by 0.39% in Q2 2026, selling an estimated $43.5K and leaving 51,588 shares worth $13M. The position accounts for 0.48% of the portfolio, ranked #38.

Meeder Advisory Services first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Meeder Advisory Services held 51,588 shares of AbbVie worth $13M as of Q2 2026.
Meeder Advisory Services sold 202 AbbVie shares in Q2 2026, an estimated $43.5K.
AbbVie made up 0.48% of Meeder Advisory Services's portfolio in Q2 2026, its #38 holding.
Meeder Advisory Services first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.